Search

everythinglearnresearchcommunity

for

Search:↓

Five molecular elements identified as potential future targets for hair loss therapy.

Platelet-rich plasma combined with other treatments improves acne scars better than those treatments alone.

5-alpha reductase inhibitors slightly increase depression risk, but the risk varies based on the control group used.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

Alopecia patients have higher heart disease risk; statins and finasteride may help.

Finasteride toxicity information is limited, poor quality, and biased.

Finasteride helps hair growth but may cause sexual side effects.

Finger length ratios are not linked to the number of specific gene repeats affecting testosterone sensitivity.

Oriental herbal medicine with moxibustion may improve pregnancy rates and other symptoms in PCOS, but more high-quality research is needed.

Androgenetic alopecia negatively affects quality of life and self-esteem, especially in women, but not depression.

Spironolactone does not increase cancer risk and may lower prostate cancer risk, but more research is needed.

Dutasteride is the most effective hair loss treatment after 24 weeks, but finasteride leads to the most hair growth after 48 weeks.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

Imiquimod may be a better non-surgical treatment for cervical pre-cancer, but its effectiveness for vaginal pre-cancer is unclear, and it has some side effects.

Genetic factors, skin barrier, immune function, and obesity influence risk of fungal skin infections.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Prostate cancer screening doesn't significantly reduce death rates and has risks like overdiagnosis and side effects.

People with Alopecia Areata are more likely to have certain health issues like ulcerative colitis and type 1 diabetes, but less likely to have others like hypertension and type 2 diabetes.

Platelet-rich plasma is effective and safe for hair growth and facial rejuvenation.

Low-level laser therapy effectively improves hair growth in androgenetic alopecia with minimal side effects.

Dutasteride is more effective than finasteride for treating BPH without extra safety risks.

Platelet-rich plasma (PRP) effectively improves acne scars.

Hormone treatment before hypospadias surgery can increase penis size and reduce surgery complications.

Finasteride helps improve hair growth in men with hair loss but may increase the risk of erectile dysfunction.

Photobiomodulation may improve certain health conditions, but more high-quality research is needed.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Platelet-rich plasma may improve hair transplant results.

People with Alopecia areata often have lower Vitamin D levels.

Early-onset hair loss is linked to Parkinson's disease and decreased fertility.